SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-041081
Filing Date
2023-02-16
Accepted
2023-02-16 16:17:05
Documents
18
Period of Report
2023-02-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d426940d8k.htm   iXBRL 8-K 33100
2 EX-1.1 d426940dex11.htm EX-1.1 184622
3 EX-4.1 d426940dex41.htm EX-4.1 92575
4 EX-4.2 d426940dex42.htm EX-4.2 98023
5 EX-5.1 d426940dex51.htm EX-5.1 17527
9 GRAPHIC g426940g0216101158092.jpg GRAPHIC 1843
10 GRAPHIC g426940g0216101429254.jpg GRAPHIC 2345
  Complete submission text file 0001193125-23-041081.txt   660856

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20230214.xsd EX-101.SCH 2866
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20230214_lab.xml EX-101.LAB 17236
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20230214_pre.xml EX-101.PRE 10823
12 EXTRACTED XBRL INSTANCE DOCUMENT d426940d8k_htm.xml XML 3225
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 23638715
SIC: 3841 Surgical & Medical Instruments & Apparatus